ARCELLX SHARES JUMP 10.6% PREMARKET AFTER CO ANNOUNCES POSITIVE DATA FOR ITS STUDY IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

Reuters · 1d ago

Please log in to view news